BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6648368)

  • 21. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
    Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
    J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A monoclonal antibody (VEP10) against an antigen shared by human large granular lymphocytes, thymocytes and activated T cells.
    Rumpold H; Kraft D; Obexer G; Böck G; Möschl P
    Immunology; 1983 Jun; 49(2):265-72. PubMed ID: 6602090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies which distinguish between human NK cells and cytotoxic T lymphocytes.
    Zarling JM; Kung PC
    Nature; 1980 Nov; 288(5789):394-6. PubMed ID: 6968872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A monoclonal antibody reactive with human peripheral blood monocytes.
    Breard J; Reinherz EL; Kung PC; Goldstein G; Schlossman SF
    J Immunol; 1980 Apr; 124(4):1943-8. PubMed ID: 6988511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells.
    Itoh K; Platsoucas CD; Balch CM
    Cell Immunol; 1987 Sep; 108(2):495-500. PubMed ID: 3113744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
    van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
    J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface receptors and immune activity of purified human circulating mononuclear cells. III. The mechanisms of lysis, by lymphocytes and monocytes, of target cells in the lymphocyte-dependent and monocyte-dependent ADCC, NK, NOCC, and MICC cytotoxic reactions.
    Richter M; Kazaniwsky N
    Cell Immunol; 1987 Sep; 108(2):297-312. PubMed ID: 3621351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural and antibody-dependent cellular cytotoxicity in tumour-adherent T lymphocytes: expression of Fc receptors and of a human T-subgroup-specific antigen.
    Feucht HE; Hadam MR; Lohmeyer J; Frank F; Reiber EP; Riethmüller G
    Scand J Immunol; 1981 May; 15(5):483-92. PubMed ID: 6179156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of cell-mediated cytotoxicity at the single-cell level. VII. Trigger of the lethal hit event is distinct for NK/K and LDCC effector cells as measured in the two-target conjugate assay.
    Bradley TP; Bonavida B
    Cell Immunol; 1984 Jan; 83(1):199-207. PubMed ID: 6420079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of monocytes and natural killer cells in mediating antibody-dependent lysis of colorectal tumour cells.
    Abdullah N; Greenman J; Pimenidou A; Topping KP; Monson JR
    Cancer Immunol Immunother; 1999 Dec; 48(9):517-24. PubMed ID: 10602889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties of human natural interferon-producing cells stimulated by tumor cell lines.
    Rönnblom L; Ramstedt U; Alm GV
    Eur J Immunol; 1983 Jun; 13(6):471-6. PubMed ID: 6574913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of K562-induced human natural killer cell inactivation using highly enriched effector cells isolated via a new single-step sheep erythrocyte rosette assay.
    Abrams SI; Brahmi Z
    Ann Inst Pasteur Immunol; 1988; 139(4):361-81. PubMed ID: 3166753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC.
    Rolstad B; Fossum S
    Immunology; 1987 Feb; 60(2):151-7. PubMed ID: 2434415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.
    Hercend T; Griffin JD; Bensussan A; Schmidt RE; Edson MA; Brennan A; Murray C; Daley JF; Schlossman SF; Ritz J
    J Clin Invest; 1985 Mar; 75(3):932-43. PubMed ID: 3884668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin 2.
    Blanchard DK; Stewart WE; Klein TW; Friedman H; Djeu JY
    J Immunol; 1987 Jul; 139(2):551-6. PubMed ID: 3496384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
    Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
    J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumoricidal activity of human monocytes: evidence for cytolytic function distinct from that of NK cells.
    Kleinerman ES; Herberman RB
    J Immunol; 1984 Jul; 133(1):4-6. PubMed ID: 6373931
    [No Abstract]   [Full Text] [Related]  

  • 40. A distinct lymphocyte subset displaying spontaneous cytotoxic activity against chicken erythrocytes. Morphological, cytochemical, immunocytochemical and functional characterization.
    Magyarlaki T; Szekeres J; Matolcsy A
    Acta Morphol Hung; 1991; 39(1):21-32. PubMed ID: 1684691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.